Results 191 to 200 of about 19,806 (216)

Separation, Purification, and Detection of cfDNA in a Microfluidic Device

Biochip Journal, 2020
Jong Min Lee, Bong Geun Chung, Christian D Ahrberg   +2 more
exaly  

Assessing nuclear versus mitochondrial cell-free DNA (cfDNA) by qRT-PCR and droplet digital PCR using a piglet model of perinatal asphyxia

Molecular Biology Reports, 2022
Xiaoran Lai, Lars O. Baumbusch, Rønnaug Solberg   +2 more
exaly  

Time-Dependent Apparent Increase in dd-cfDNA Percentage in Clinically Stable Patients Between One and Five Years Following Kidney Transplantation

Clinical Chemistry, 2020
Vedat Schwenger, Michael Oellerich, Philip D Walson   +2 more
exaly  

Impact of cfDNA Reference Materials on Clinical Performance of Liquid Biopsy NGS Assays

Cancers, 2023
Verena Steinke-Lange, Ariane Hallermayr, Elke Holinski-Feder   +2 more
exaly  

People also looked at

Frontiers in Genetics, 2020
Bin Yu, Guodong Zhao, Ying Xue
exaly  

Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study

Cancers, 2022
Marco Bono, Lorena Incorvaia, Giuseppe BADALAMENTI   +2 more
exaly  

cfDNA methylation analysis detects RCC

Nature Reviews Urology, 2020
openaire   +2 more sources

Preoperative Mutational Analysis of Circulating Tumor Cells (CTCs) and Plasma-cfDNA Provides Complementary Information for Early Prediction of Relapse: A Pilot Study in Early-Stage Non-Small Cell Lung Cancer

Cancers, 2023
Athina Markou, Athanasios Kotsakis, Evi S Lianidou   +2 more
exaly  

cfDNA als metabolischer Marker

Sports Orthopaedics and Traumatology, 2018
D. Ochmann, S. Wenzel, C. Kreutz, M. Dreher, P. Simon   +4 more
openaire   +1 more source

Combinations of plasma cfDNA concentration, integrity and tumor markers are promising biomarkers for early diagnosis of non-small cell lung cancer

Heliyon, 2023
Sai Ren, Tingjia Chai
exaly